Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

The guide explains how to study human and mouse sebaceous glands using various staining and imaging techniques, and emphasizes the need for standardized assessment methods.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Hair loss in women may have causes other than hormones.

Men with enlarged prostates often have more severe baldness.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Minoxidil helps grow longer, thicker hair in bald scalps of stumptailed macaques, and early treatment is more effective.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Prolactin slows down hair growth in mice.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Minoxidil needs activation to work, and minoxidil sulfate helps with hair growth and blood pressure.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.